Patents by Inventor George W. Matcham

George W. Matcham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6207695
    Abstract: Chiral fungicides and compositions containing the same are provided. Also provided are methods for using the compositions of the present invention for inhibiting the growth of fungi, including phytotoxic fungi. The use of a single isomer in treating particular plant species and against particular fungi allows for selective inhibition of fungal growth with reduced fungicidal phytotoxic effects.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: March 27, 2001
    Assignee: Celgene Corporation
    Inventors: Richard A. Nelson, Norman W. Thomas, George W. Matcham, Sue L. Lin, Minghua Zhang, Craig M. Lewis
  • Patent number: 6133018
    Abstract: 2-Aminopropane is used as the amine donor in the stereoselective synthesis of a chiral amine from a ketone with a transaminase. In a typical embodiment, (S)-1-methoxy-2-aminopropane is prepared by bringing methoxyacetone into contact with a transaminase in the presence of 2-aminopropane as an amine donor until a substantial amount of methoxyacetone is converted to (S)-1-methoxy-2-aminopropane and 2-aminopropane is converted to acetone. In a second embodiment, L-alanine is prepared by bringing pyruvic acid into contact with a transaminase in the presence of 2-aminopropane as an amine donor.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: October 17, 2000
    Assignee: Celgro
    Inventors: Wei Wu, Mohit B. Bhatia, Craig M. Lewis, Wei Lang, Alice L. Wang, George W. Matcham
  • Patent number: 6107521
    Abstract: N,N-disubstituted amines in which the amino nitrogen atom is bound to the carbon atom of an aromatic ring disubstituted in the positions ortho to the carbon atom, are prepared by allowing a primary amine and a compound in which an ortho, ortho-disubstituted aromatic compound carrying a nucleofuge substituent, to react in a basic environment in the presence of a catalytic palladium(0) complex and a ligand, the ratio of palladium complex to ligand being greater than at least 1:1. A typical embodiment involves the reaction of 2-methyl-6-ethylphenyl-trifluoromethylsulfonate and (S)-1-methoxy-2-aminopropane in the presence of bis(dibenzylideneacetone)palladium, tri-tert.-butylphosphine, and sodium tert.-butoxide to yield (S)-N-(1-methoxyprop-2-yl)-2-methyl-6-ethylphenylamine.
    Type: Grant
    Filed: December 14, 1999
    Date of Patent: August 22, 2000
    Assignee: Celgro
    Inventors: Sue L. Lin, Weixia M. Zhou, George W. Matcham
  • Patent number: 5866512
    Abstract: Compositions for controlling growth of plant species, and methods for using the compositions, are disclosed. The compositions contain a single-isomer enantiomeric S-benzyl thiocarbamate and are particularly useful in controlling annual weeds associated with rice, soybeans and corn.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: February 2, 1999
    Assignee: Celgene Corporation
    Inventors: George W. Matcham, Norman W. Thomas
  • Patent number: 5424454
    Abstract: L-alanyl-L-proline is stereoselectively prepared catalytically hydrogenating an N-(2-iminopropionyl)-L-proline in the presence of a metal hydrogenolysis catalyst and at a pH of less than about 4. Also disclosed are improved processes for production of N-pyruvyl-L-proline in which L-proline and a 2,2-disubstituted propionyl halide are allowed to react at a pH of at least 9 to produce an L-proline intermediate which is hydrolyzed at a pH range of from about 6.5 to about 8.5 to yield N-pyruvyl-L-proline.
    Type: Grant
    Filed: May 26, 1994
    Date of Patent: June 13, 1995
    Assignee: Celgene Corporation
    Inventors: Beverly W. Burbaum, Chunshi Li, George W. Matcham
  • Patent number: 5360724
    Abstract: One chiral form of a 1-aryl-2-aminopropane is produced in preference to its enantiomer by allowing a 1-arylpropan-2-one to react with a 1-amino-1-phenylethane of predominantly one chiral form and reducing the resultant 1-(1-arylprop-2-ylideneimino)-1-phenylethane to yield phenylethane and a mixture of 1-aryl-2-aminopropanes in which one chiral form thereof is present in preference to its enantiomer. The mixture of 1-aryl-2-aminopropanes then is subjected to the action of an omega-amino acid transaminase which converts one of the two chiral forms of 1-aryl-2-aminopropane into the corresponding arylpropanone which can be separated from the remaining chiral form of the 1-aryl-2-aminopropane.
    Type: Grant
    Filed: December 18, 1992
    Date of Patent: November 1, 1994
    Assignee: Celgene Corporation
    Inventors: George W. Matcham, Seujo Lee
  • Patent number: 5319098
    Abstract: L-Alanyl-L-proline is stereoselectively prepared catalytically hydrogenating an N-(2-iminopropionyl)-L-proline in the presence of a metal hydrogenolysis catalyst and at a pH of less than about 4. Also disclosed are improved processes for production of pyruvylproline in which L-proline and a 2,2-disubstituted propionyl halide are allowed to react at a pH of at least 9 to produce an L-proline intermediate which is hydrolyzed at a pH range of from about 6.5 to about 8.5 to yield N-pyruvyl-L-proline.
    Type: Grant
    Filed: May 18, 1993
    Date of Patent: June 7, 1994
    Assignee: Celgene Corporation
    Inventors: Beverly W. Burbaum, Chunshi Li, George W. Matcham
  • Patent number: 5300437
    Abstract: Amines in which the amino group is on a secondary carbon atom which is chirally substituted can be enantiomerically enriched by the action of an omega-amino acid transaminase which has the property of preferentially converting one of the two chiral forms to a ketone. The process also can be used to stereoselectively synthesize one chiral form from ketones substantially to the exclusion of the other.
    Type: Grant
    Filed: October 9, 1992
    Date of Patent: April 5, 1994
    Assignee: Celgene Corporation
    Inventors: David I. Stirling, George W. Matcham, Andrew L. Zeitlin
  • Patent number: 5169780
    Abstract: Amines in which the amino group is on a secondary carbon atom which is chirally substituted can be enantiomerically enriched by the action of an omega-amino acid transaminase which has the property of preferentially converting one of the two chiral forms to a ketone. The process can be used to stereoselectively sythesize one chiral form from ketones substantially to the exclusion of the other. An aqueous solution of chiral amines after being brought into contact with an omega-amino acid transaminase and an amino acceptor is treated with a water-immiscible organic solvent, the aqueous and organic phases are separated, and the aqueous phase can be recirculated for further contact with the transaminase.
    Type: Grant
    Filed: July 9, 1990
    Date of Patent: December 8, 1992
    Assignee: Celgene Corporation
    Inventors: David I. Stirling, Andrew L. Zeitlin, George W. Matcham, James D. Rozzell, Jr.
  • Patent number: 5166060
    Abstract: Pyridine-2,3-dicarboxylic acids are prepared by the action of 2,3-dihydroxybenzoate-3,4-dioxygenase on 2,3-dihydroxybenzoic acids in a liquid medium which lacks active decarboxylase and which has a pH from 4 to 9, an ionic strength below about 1 molar, and a low concentration of metal cations and complex anions. In close temporal proximity, the 2-hydroxy-3-carboxymuconic acid semialdehyde which forms is allowed to react with a source of ammonia or a primary amine, avoiding substantial decarboxylation.
    Type: Grant
    Filed: March 31, 1989
    Date of Patent: November 24, 1992
    Assignee: Celgene Corporation
    Inventors: Randall A. Roehl, George W. Matcham, David I. Stirling
  • Patent number: 4950606
    Abstract: Amines in which the amino group is on a secondary carbon atom which is chrially substituted can be enantiomerically enriched by the action of an omega-amino acid transaminase which has the property of preferentially converting one of the two chiral forms to a ketone. The process also can be used to stereoselectively synthesize one chiral form from ketones substantially to the exclusion of the other.
    Type: Grant
    Filed: June 22, 1989
    Date of Patent: August 21, 1990
    Assignee: Celgene Corporation
    Inventors: David I. Stirling, Andrew L. Zeitlin, George W. Matcham